Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03900832 · ClinicalTrials.gov registry record · Early Phase 1
Effects of Heating on Exercise Pressor Reflex in Peripheral Artery Disease: Exercise Ability
A Early Phase 1 study, sponsored by Milton S. Hershey Medical Center.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 33
- Enrollment target
NCT03900832: Completed Early Phase 1 study, sponsored by Milton S. Hershey Medical Center.
NCT03900832 is a Early Phase 1 study that has completed, run by Milton S. Hershey Medical Center. The registered enrollment target is 33 participants, below the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (38% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03900832, a Early Phase 1 study, has completed, sponsored by Milton S. Hershey Medical Center.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 33 participants
- Enrollment target
Study Summary
The study objectives of this projects are to examine the hypothesis that the sympathetic and blood pressure responses to exercise will be attenuated during and after heat exposure in patients with peripheral artery disease, via altering the sensitivity of the muscle afferent receptors.
Primary Outcome
Walking time on treadmill using Gardner protocol
Interventions
- OTHER Without Heating
- OTHER Warm Bath
- OTHER Neutral Bath
- OTHER Heating Suit
- OTHER Lower limb warm water immersion
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 33 participants |
| Start Date | 2019-05-15 |
| Est. Completion | 2025-07-31 |
| Phase | Early Phase 1 |
What the finished NCT03900832 record still lists
NCT03900832 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 33 participants, a relatively small participant target, below the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (38% lower).
The record links to 0 conditions, and to 5 interventions - of which Without Heating is the first listed.
NCT03900832 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03900832 about?
NCT03900832 is a clinical study titled "Effects of Heating on Exercise Pressor Reflex in Peripheral Artery Disease: Exercise Ability". The study objectives of this projects are to examine the hypothesis that the sympathetic and blood pressure responses to exercise will be attenuated during and after heat exposure in patients with peripheral artery disease, via altering the sensitivity of the muscle afferent receptors.
What is the current status of trial NCT03900832?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 33 participants. The study started on 2019-05-15. Estimated completion is 2025-07-31.
What interventions are being tested in trial NCT03900832?
The interventions under investigation include: Without Heating (OTHER), Warm Bath (OTHER), Neutral Bath (OTHER), Heating Suit (OTHER), Lower limb warm water immersion (OTHER).
Who is sponsoring clinical trial NCT03900832?
This trial is sponsored by Milton S. Hershey Medical Center, which has 396 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03900832's enrollment target sits among peer trials
33 763rd of 2000 higher than 1,226 of 2,000 other Early Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Early Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02861898 · 33 participants · Phase 1
Super-selective Intra-arterial Repeated Infusion of Cetuximab for the Treatment of Newly Diagnosed Glioblastoma
- NCT04871607 · 33 participants · Phase 2
Yttrium-90 Labeled Anti-CD25 Monoclonal Antibody Combined With BEAM Chemotherapy Conditioning for the Treatment of Primary Refractory or Relapsed Hodgkin Lymphoma
- NCT05071937 · 33 participants · Phase 2
ZEN003694 Combined With Talazoparib in Patients With Recurrent Ovarian Cancer
- NCT05168618 · 33 participants · Phase 2
Cabozantinib and Atezolizumab for the Treatment of Metastatic Castration-Resistant Prostate Cancer, The AtezoCab Trial
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI